(S,S)-2,8-Diazabicyclo[4,3,0]nonane
(S,S)-2,8-Diazabicyclo[4,3,0]nonane Basic information
- Product Name:
- (S,S)-2,8-Diazabicyclo[4,3,0]nonane
- Synonyms:
-
- [S,S]-2,8-Diazabicyclo[4.3.0]Nonane98%
- (S,S)-2,8-Diazabicyclo[4,3,0]onoane
- (S,S)-2,8-DIAZABICYCLO[4,3,0]NONANE [FOR MOXIFLOXACIN]
- (1S,6S)-2,8-Diazacyclo[4,3,0]nonane ,99%
- Moxifloxacin Intermediate 1
- 2,8-Diazabicyclo[4.3.0]nonane,Cis-Octahydropyrrolo[3,4-B]Pyridine
- cis-Octahydropyrrolo[3,4-b]pyridine/(R,R)-2,8-Diazabicyclo[4,3,0]nonane
- (1R,6R)-2,8-Diazabicyclo[4,3,0]nonane
- CAS:
- 151213-42-2
- MF:
- C7H14N2
- MW:
- 126.2
- EINECS:
- 604-779-3
- Product Categories:
-
- Heterocycle-Pyridine series
- pharmacetical
- API intermediates
- pharmaceutical intermediates
- Mol File:
- 151213-42-2.mol
(S,S)-2,8-Diazabicyclo[4,3,0]nonane Chemical Properties
- Boiling point:
- 198.5±8.0 °C(Predicted)
- Density
- 0.950±0.06 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- Chloroform (Slightly), Methanol (Slightly), Water
- pka
- 11.11±0.20(Predicted)
- form
- Oil
- color
- Colourless to Yellow
- InChI
- InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2/t6-,7+/m1/s1
- InChIKey
- KSCPLKVBWDOSAI-RQJHMYQMSA-N
- SMILES
- [C@]12([H])CNC[C@@]1([H])CCCN2
- CAS DataBase Reference
- 151213-42-2(CAS DataBase Reference)
(S,S)-2,8-Diazabicyclo[4,3,0]nonane Usage And Synthesis
Chemical Properties
Clear light red liquid
Uses
(1R,6R)-2,8-Diazabicyclo[4.3.0]nonane is a chiral reagent used in the synthesis of pyrrolopyrimidine derivatives as dual DNA gyrase B and topoisomerase IV inhibitors and potential antibacterial agents.
Synthesis
151213-43-3
151213-42-2
The general procedure for the synthesis of (4aR,7aR)-octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine from (4aR,7aR)-octahydro-1H-pyrrolo[3,4-b]pyridine is as follows: 19.4 g (0.09 mol) of (R,R)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane was dissolved in methanol with the addition of 3.96 g of 5% palladium/activated carbon catalyst and hydrogenated at 90 °C and 130 °C for 5 hours. Upon completion of the reaction, the catalyst was removed by filtration and the catalyst was washed with methanol. The filtrate was concentrated under vacuum and the residue was directly distilled without fractionation. A final product of 9.61 g was obtained in 85% yield of the theoretical value. The boiling point of the product was 45-58°C/0.08 mbar.
References
[1] Patent: WO2003/106450, 2003, A1. Location in patent: Page column 58
[2] Patent: US5468742, 1995, A
[3] Patent: US5480879, 1996, A
[4] Oriental Journal of Chemistry, 2013, vol. 29, # 1, p. 241 - 246
(S,S)-2,8-Diazabicyclo[4,3,0]nonaneSupplier
- Tel
- 18163336578
- 2139086656@qq.com
- Tel
- 0576-89085261 15867635987
- jasonhu09@163.com
- Tel
- 15317222985
- bingna.wang@cepharm.cn
- Tel
- 15867635987
- jasonhu09@163.com
- Tel
- 15800805830
- miao@lewoopharma.com.cn
(S,S)-2,8-Diazabicyclo[4,3,0]nonane(151213-42-2)Related Product Information
- 3-Ethyl-6,7,8,9-tetrahydro-9-hydroxy-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one
- 3-pentylisoindolin-1-one
- Acotiamide INT
- (4aS,7aS)-1-methyloctahydro-1H-pyrrolo[3,4-b]pyridine
- 3-ethyl-9-hydroxy-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one
- 3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone)
- Indene
- 7-Aminocephalosporanic acid
- 6-Aminopenicillanic acid
- Ribostamycin sulfate
- DBU
- N-NONANE
- CIS-OCTAHYDROPYRROLO[3,4-B]PYRIDINE
- 9-methyl-3,9-diazedicyclo(4,2,1)nonane
- (S,S)-2,8-Diazabicyclo[4,3,0]nonane
- Moxifloxacin Methyl Ester
- 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester
- 3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-(2-carboxyethyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-